A disproportionality analysis of drug-drug interactions of tizanidine and CYP1A2 inhibitors from the FDA Adverse Event Reporting System (FAERS).
Citation
Villa-Zapata L, Gómez-Lumbreras A, Horn J, Tan MS, Boyce RD, Malone DC. A disproportionality analysis of drug-drug interactions of tizanidine and CYP1A2 inhibitors from the FDA Adverse Event Reporting System (FAERS). Drug Saf. 2022 Aug;45(8):863-871. doi: 10.1007/s40264-022-01200-4. Epub 2022 Jul 14. PMID: 35834155.
Principal Investigator
Project Name
Technology
Document Type
Research Method